The 2016 General Assembly Session is under way, and MedChi, The Maryland State Medical Society, and many physicians in the Chesapeake Physician community have common legislative goals which align with the mission of MedChi — to serve as Maryland’s foremost advocate and resource for physicians, their patients, and the public health.
Also posted in Cover Stories
By the end of 2016, medical cannabis (marijuana) is likely to become available as a new therapeutic measure for Maryland doctors. Del. Dan Morhaim, MD and Gene Ransom, MedChi CEO, discuss why physicians should not fear prescribing medical cannabis to appropriate patients.
Also posted in Cover Stories
Primary Care Physician Reentry Act Would Reduce America’s Shortage of Primary Care Physicians and Provide Communities with More Access to Quality Health Care Congressman John Sarbanes (D-Md.) recently introduced the Primary Care Physician Reentry Act, which would tackle America’s shortage of primary care physicians by supporting programs that retrain doctors to work in health centers […]
If anyone can take on Baltimore City residents’ many health issues, it’s Baltimore City Health Commissioner Leana Wen, MD. When she’s not giving TED talks, you can likely find her encouraging physicians to minimize opiate use, teaching people how to prevent heroin deaths, or seeking new ways to reduce violence.
Joe DeMattos, Jr., MA, head of HFAM, discusses how long-term care facilities have changed and how they can keep patients healthier while reducing healthcare system costs.
Congressman John Sarbanes (D-Md.) issued the following statement on May 21, 2015, after H.R. 6, the 21st Century Cures Act, passed the full Energy and Commerce Committee with bipartisan support. The bill will increase biomedical research and accelerate the approval process for new medical devices and prescription drugs, giving patients more access to life-saving treatments. […]
In March 2015, the Centers for Medicare and Medicaid Services (CMS) rolled out the proposed rule for Stage 3, which they declared will be the final stage of its Meaningful Use (MU) EHR incentive program. This stage is scheduled to begin in 2017.
A conversation with Jesse Pines, MD, MBA, Director of the Office of Clinical Practice Innovation at George Washington University regarding the impact of the Affordable Care Act on the current acute care system, and cost containment/utilization approaches.
Maryland SB 69/ HB 181 (“State Board of Pharmacy – Sterile Compounding – Compliance by Nonresident Pharmacies and Repeal of Permit Requirement”) sponsored by Maryland Legislative Senator Conway and Delegate Hill respectively, is MedChi (The Maryland State Medical Society) initiated legislation that would repeal the provisions of the Maryland Pharmacy Act passed in 2013 that […]
Despite his 28 years in the Maryland state legislature, Speaker Michael Busch has never taken the splendor of the House chamber for granted. The chamber is an inspirational setting for the years of legislative wrangling that have taken place within its walls.